Literature DB >> 25615609

"Uncovering" the recovery of natural killer cells after reduced-intensity conditioning transplantation.

Veronika Bachanova1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25615609      PMCID： PMC5577011          DOI： 10.1016/j.bbmt.2015.01.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  8 in total

1.  Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Authors:  Stella M Davies; Loredana Ruggieri; Todd DeFor; John E Wagner; Daniel J Weisdorf; Jeffrey S Miller; Andrea Velardi; Bruce R Blazar
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

2.  Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Authors:  Kevin C Conlon; Enrico Lugli; Hugh C Welles; Steven A Rosenberg; Antonio Tito Fojo; John C Morris; Thomas A Fleisher; Sigrid P Dubois; Liyanage P Perera; Donn M Stewart; Carolyn K Goldman; Bonita R Bryant; Jean M Decker; Jing Chen; Tat'Yana A Worthy; William D Figg; Cody J Peer; Michael C Sneller; H Clifford Lane; Jason L Yovandich; Stephen P Creekmore; Mario Roederer; Thomas A Waldmann
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

3.  Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Authors:  Loredana Ruggeri; Antonella Mancusi; Marusca Capanni; Elena Urbani; Alessandra Carotti; Teresa Aloisi; Martin Stern; Daniela Pende; Katia Perruccio; Emanuela Burchielli; Fabiana Topini; Erika Bianchi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

4.  KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Authors:  Sarah Cooley; Valarie McCullar; Rosanna Wangen; Tracy L Bergemann; Stephen Spellman; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

5.  Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.

Authors:  Caroline Pical-Izard; Roberto Crocchiolo; Samuel Granjeaud; Eloise Kochbati; Sylvaine Just-Landi; Christian Chabannon; Coralie Frassati; Christophe Picard; Didier Blaise; Daniel Olive; Cyril Fauriat
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-09       Impact factor: 5.742

6.  Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Julie Curtsinger; Xianghua Luo; Edmund K Waller; Claudio Anasetti; Daniel Weisdorf; Jeffrey S Miller
Journal:  J Immunol       Date:  2012-10-17       Impact factor: 5.422

7.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Elizabeth Trachtenberg; Tracy L Bergemann; Koy Saeteurn; John Klein; Chap T Le; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

8.  Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.

Authors:  Andres Wiernik; Bree Foley; Bin Zhang; Michael R Verneris; Erica Warlick; Michelle K Gleason; Julie A Ross; Xianghua Luo; Daniel J Weisdorf; Bruce Walcheck; Daniel A Vallera; Jeffrey S Miller
Journal:  Clin Cancer Res       Date:  2013-05-20       Impact factor: 12.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.